Sante Capital Fund’s Twist Bioscience TWST Stock Holding History

Sante Capital Fund’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,623	Closed	-$483K	–	108
2021 Q2	$483K	Buy	+3,623	New	+$421K	0.2%	102

Other funds holding TWST

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Sante Capital Fund's TWST Position: Q3 2021 in Review

Sante Capital Fund sold out of Twist Bioscience (TWST) in Q3 2021, closing a stake of 3,623 shares — an estimated $483K sold.

Sante Capital Fund first reported a position in TWST in Q2 2021 and held it in 1 quarter. The position peaked at $483K in Q2 2021. 235 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

Sante Capital Fund reported no remaining Twist Bioscience position as of Q3 2021 after selling out during the quarter.
Sante Capital Fund sold 3,623 Twist Bioscience shares in Q3 2021, an estimated $483K.
Sante Capital Fund first reported a position in Twist Bioscience in Q2 2021 and held it in 1 quarter.
Sante Capital Fund's Twist Bioscience position peaked at $483K in Q2 2021.
235 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on Sante Capital Fund's 13F filing for Q3 2021, filed 15 Nov 2021.